A Study of JNJ-95597528 in Participants With Moderate to Severe Atopic Dermatitis
Public ClinicalTrials.gov record NCT07230860. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of JNJ-95597528 for the Treatment of Adult Participants With Moderate to Severe Atopic Dermatitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to assess how well JNJ-95597528 works compared to placebo in participants with moderate to severe atopic dermatitis (AD).
Study identification
- NCT ID
- NCT07230860
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 189 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 20, 2026 (Actual)
- Primary completion
- Nov 19, 2026 (Estimated)
- Completion
- Feb 10, 2028 (Estimated)
- Last update posted
- Sep 25, 2026
2026 – 2028
United States locations
- U.S. sites
- 12
- U.S. states
- 9
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| First OC Dermatology | Fountain Valley | California | 92708 | — |
| University of California Los Angeles - Division of Dermatology | Los Angeles | California | 90024 | — |
| Southern California Dermatology | Santa Ana | California | 92701 | — |
| Driven Research LLC | Miami | Florida | 33126 | — |
| Arlington Dermatology | Rolling Meadows | Illinois | 60008 | — |
| Dawes Fretzin Clinical Research Group | Indianapolis | Indiana | 46250 | — |
| Henry Ford Health System | Detroit | Michigan | 48202 | — |
| Red River Research Partners LLC | Fargo | North Dakota | 58103 | — |
| Oregon Dermatology and Research Center | Portland | Oregon | 97210 | — |
| Clinical Research Philadelphia | Philadelphia | Pennsylvania | 19114 | — |
| Center for Clinical Studies | Houston | Texas | 77004 | — |
| Progressive Clinical Research | San Antonio | Texas | 78213 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 50 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07230860, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 25, 2026 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07230860 live on ClinicalTrials.gov.